The emerging role of the Histamine H4 receptor in anti-inflammatory therapy

Current Topics in Medicinal Chemistry

Volumn 6, Issue 13, 2006, Pages 1365-1373

  Lim, Herman D ^a   Smits, Rogier A ^a   Leurs, Rob ^a   De Esch, Iwan J P ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Arthritis; Asthma; Benzimidazole scaffold; Inflammation; Inflammatory Bowel Disease (IBD); JNJ 7777120; Rheumatoid

Indexed keywords

2 CYANO 1 METHYL 3 [5 (1H IMIDAZOL 4(5) YL)TETRAHYDROFURAN 2 YL]METHYLGUANIDINE; 4 METHYLHISTAMINE; AMINOMETHYLAZETIDINE; AMINOMETHYLPYRROLIDINE; AMINOPYRIDINE DERIVATIVE; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; CLOBENPROPIT; CLOZAPINE; CYCLOOXYGENASE 2; DIMAPRIT; HISTAMINE; HISTAMINE AGONIST; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR; HISTAMINE H4 RECEPTOR AGONIST; HISTAMINE H4 RECEPTOR ANTAGONIST; IMIDAZOLE; INFLIXIMAB; JNJ 7777120; LIGAND; OCTAHYDRO 6H PYRROLOPYRIDINE; OUP 16; RECEPTOR PROTEIN; THIOPERAMIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VUF 6002; VUF 6884; ZOLANTIDINE;

ALLERGIC DISEASE; ASTHMA; CANCER THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORECTAL CANCER; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENTERITIS; HUMAN; INFLAMMATORY DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRURITUS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

EID: 33746639548     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/15680266106061365     Document Type: Review

References (57)

1. Parsons, M. E.; Ganellin, C. R. Histamine and its receptors. Br. J. Pharmacol. 2006, 147 (Suppl 1), S127-135.
2. 3 receptor drugs. Nat. Rev. Drug Discov. 2005, 4, 107-120.
3. Clark, R. A.; Gallin, J. I.; Kaplan, A. P. The selective eosinophil chemotactic activity of histamine. J. Exp. Med. 1975, 142, 1462-1476.
4. Raible, D. G.; Lenahan, T.; Fayvilevich, Y.; Kosinski, R.; Schulman, E. S. Pharmacologic characterization of a novel histamine receptor on human eosinophils. Am. J. Respir. Crit. Care Med. 1994, 149, 1506-1511.
5. Oda, T.; Morikawa, N.; Saito, Y; Masuho, Y.; Matsumoto, S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem. 2000, 275, 36781-36786.
6. 4) expressed in bone marrow. Mol. Pharmacol. 2001, 59, 420-426.
7. Morse, K. L.; Behan, J.; Laz, T. M.; West, R. E., Jr.; Greenfeder, S. A.; Anthes, J. C.; Umland, S.; Wan, Y.; Hipkin, R. W.; Gonsiorek, W.; Shin, N.; Gustafson, E. L.; Qiao, X.; Wang, S.; Hedrick, J. A.; Greene, J. A.; Bayne, M.; Monsma, F. J., Jr. Cloning and characterization of a novel human histamine receptor. J. Pharmacol. Exp. Ther. 2001, 296, 1058-1066.
8. Zhu, Y.; Michalovich, D.; Wu, H.; Tan, K. B.; Dytko, G. M.; Mannan, I. J.; Boyce, R.; Alston, J.; Tierney, L. A.; Li, X.; Herrity, N. C.; Vawter, L.; Sarau, H. M.; Ames, R. S.; Davenport, C. M.; Hieble, J. P.; Wilson, S.; Bergsma, D. J.; Fitzgerald, L. R. Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol. Pharmacol. 2001, 59, 434-441.
9. Nguyen, T.; Shapiro, D. A.; George, S. R.; Setola, V.; Lee, D. K.; Cheng, R.; Rauser, L.; Lee, S. P.; Lynch, K. R.; Roth, B. L.; O'Dowd, B. F. Discovery of a novel member of the histamine receptor family. Mol. Pharmacol. 2001, 59, 427-433.
10. Lovenberg, T. W.; Roland, B. L.; Wilson, S. J.; Jiang, X.; Pyati, J.; Huvar, A.; Jackson, M. R.; Erlander, M. G. Cloning and functional expression of the human histamine H3 receptor. Mol. Pharmacol. 1999, 55, 1101-1107.
11. Coge, F.; Guenin, S. P.; Rique, H.; Boutin, J. A.; Galizzi, J. P. Structure and expression of the human histamine H4-receptor gene. Biochem. Biophys. Res. Commun. 2001, 284, 301-309.
12. 4 receptor as a new therapeutic target for inflammation. Trends Pharmacol. Sci. 2005, 26, 462-469.
13. 4 receptor. Mol. Pharmacol. 2002, 62, 38-47.
14. 3 receptor. J. Pharmacol. Exp. Ther. 2002, 301, 451-458.
15. 4 polynucleotides. Patent WO 03/020907, Mar 13, 2003.
16. 4 receptors reveals substantial pharmacological species variation. J. Pharmacol. Exp. Ther. 2001, 299, 121-130.
17. 4R. Biochem. Biophys. Res. Commun. 2000, 279, 615-620.
18. 4 receptor on human eosinophils-role in eosinophil chemotaxis. J. Recept. Signal Transduct. Res. 2002, 22, 431-448.
19. 4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br. J. Pharmacol. 2004, 142, 161-171.
20. 4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J. Immunol. 2005, 174, 5224-5232.
21. 3R, in the human intestinal tract. Gut 2005, 55(4), 498-504.
22. Dy, M.; Schneider, E. Histamine-cytokine connection in immunity and hematopoiesis. Cytokine Growth Factor Rev. 2004, 15, 393-410.
23. Nakaya, M.; Takeuchi, N.; Kondo, K. Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates. Ann. Otol. Rhinol. Laryngol. 2004, 113, 552-557.
24. 4 receptor. Biochim. Biophys. Acta 2002, 1575, 135-138.
25. 4 receptor. J. Pharmacol. Sci. 2005, 98, 319-322.
26. 4 receptor agonist. J. Pharmacol. Exp. Ther. 2005, 314, 1310-1321.
27. 4 receptor. Br. J. Pharmacol. 2003, 140, 1117-1127.
28. 4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 2003, 305, 1212-1221.
29. 1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br. J. Pharmacol. 2004, 142, 374-380.
30. + T cells. J. Pharmacol. Exp. Ther. 2002, 303, 300-307.
31. Burns, S.; Hamley, P. Imidazole derivatives of piperidine as histamine antagonists. Patent WO 2005/014579, Feb 17, 2005.
32. 4-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-y1]tetrahydrofuran-2-y] methylguanidine. J. Med. Chem. 2003, 46, 3162-3165.
33. 3 receptor antagonists reach out for the clinic. Drug Discov. Today 2005, 10, 1613-1627.
34. Carruthers, N. I.; Chai, W.; Dvorak, C.; Edwards, J. P.; Grice, C. A.; Jablonowski, J. A.; Karlsson, L.; Khatuya, H.; Kreisberg, J. D.; Kwok, A. K.; Lovenberg, T.; Pio, B.; Shah, C. R.; Sun, S.; Thurmond, R. L.; Wei, J. Heterocyclic compounds. Patent WO 02072548, Mar 24, 2004.
35. 4 receptor antagonists. J. Med. Chem. 2003, 46, 3957-3960.
36. 4 receptor antagonist with anti-inflammatory properties. J. Pharmacol. Exp. Ther. 2004, 309, 404-413.
37. 4 receptor antagonists. Bioorg. Med. Chem. Lett. 2004, 14, 5251-5256.
38. 4 antagonists. J. Med. Chem. 2005, 48, 8289-8298.
39. Cai, H.; Carruthers, N. I.; Dvorak, C. A.; Edwards, J. P.; Kwok, A. K. Heterocyclic compounds. Patent WO 2004/022537, Mar 18, 2005.
40. Arienti, K.L.; Breitenbucher, J. G.; Buzard, D. J.; Edwards, J. P.; Hack, M. D.; Khatuya, H.; Kindrachuk, D. E.; Lee, A.; Venable, J. D. Benzoimidazole compounds. Patent US 2005/0070550, Mar 31, 2005.
41. Edwards, J.P; Venable, J. D. Quinoxaline compounds. Patent US 2005/ 0070527, Mar 31, 2005.
42. Lumma, W. C., Jr.; Hartman, R. D.; Saari, W. S.; Engelhardt, E. L.; Lotti, V. J.; Stone, C.A. Piperazinylquinoxalines with central serotoninmimetic activity. J. Med. Chem. 1981, 24, 93-101.
43. Sato, H.; Tanaka, K.; Shimazaki, M.; Urbahns, K.; Sakai, K.; Ganter, F.; Bacon, K. 2-Aminopyrimidine. Patent WO 2005/014556, Feb 17, 2005.
44. Sato, H.; Fukushima, K.; Shimazaki, M.; Urbahns, K.; Sakai, K.; Ganter, F.; Bacon, K. 2-Aminopiperidine derivatives. Patent WO 2005/054239, Jun 16, 2005.
45. Schneider, E.; Rolli-Derkinderen, M.; Arock, M.; Dy, M. Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol. 2002, 23, 255-263.
46. 4 receptor. J. Immunol. 2004, 173, 2078-2083.
47. 4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J. Pharmacol. Exp. Ther. 2003, 307, 1072-1078.
48. 4 receptor in zymosan-induced neutrophil recruitment from the bone marrow: comparison with carrageenan. J. Pharmacol. Exp. Ther. 2004, 310, 272-280.
49. Isaacs, K. L.; Lewis, J. D.; Sandborn, W. J.; Sands, B. E.; Targan, S. R. State of the art: IBD therapy and clinical trials in IBD. Inflamm. Bowel Dis. 2005, 11 (Suppl 1), S3-12.
50. 4 receptor antagonists on experimental colitis in the rat. Eur. J. Pharmacol. 2005, 522, 130-138.
51. Barnes, P. J. New drugs for asthma. Nat. Rev. Drug Discov. 2004, 3, 831-844.
52. O'Donoghue, M.; Tharp, M. D. Antihistamines and their role as antipruritics. Dermatol. Ther. 2005, 18, 333-340.
53. 3 receptors. J. Invest. Dermatol. 2004, 123, 116-123.
54. Sweeney, S. E.; Firestein, G. S. Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol. 2004, 36, 372-378.
55. Frewin, D. B.; Cleland, L. G.; Jonsson, J. R.; Robertson, P. W. Histamine levels in human synovial fluid. J. Rheumatol. 1986, 13, 13-14.
56. 4 receptor expression in human synovial cells obtained from patients suffering from rheumatoid arthritis. Biol. Pharm. Bull. 2005, 28, 2016-2018.
57. Cianchi, F.; Cortesini, C.; Schiavone, N.; Perna, F.; Magnelli, L.; Fanti, E.; Bani, D.; Messerini, L.; Fabbroni, V.; Perigli, G.; Capaccioli, S. The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin. Cancer Res. 2005, 11, 6807-6815.